1.
Product Overview
1.1.
Market Definition
1.2.
Scope of the Market
1.2.1.
Markets Covered
1.2.2.
Years Considered for Study
1.2.3.
Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validation
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1.
Overview of the Market
3.2.
Overview of Key Market Segmentations
3.3.
Overview of Key Market Players
3.4.
Overview of Key Regions/Countries
3.5.
Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5.
Clinical Trial Analysis
5.1.
Ongoing Clinical Trials
5.2.
Completed Clinical Trials
5.3.
Terminated Clinical Trials
5.4.
Breakdown of Pipeline, By Development Phase
5.5.
Breakdown of Pipeline, By Status
5.6.
Breakdown of Pipeline, By Study Application
5.7.
Breakdown of Pipeline, By Region
5.8.
Clinical Trials Heat Map
6.
Global Human Microbiome Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Product (Prebiotics, Probiotics, Medical Food,
Supplements, Others)
6.2.2.
By Application (Therapeutic, Diagnostic)
6.2.3.
By Disease (Infectious Disease, Endocrine and
Metabolic Disorders, Gastrointestinal Diseases, Cancer and Other Disease)
6.2.4.
By Technology (Genomics, Proteomics, Metabolomics)
6.2.5.
By Type (FMT, Peptide, Live Biotherapeutic Product and
Others)
6.2.6.
By Company (2022)
6.2.7.
By Region
6.3.
Product Market Map
7.
Asia-Pacific Human Microbiome Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1. By
Product
7.2.2. By
Application
7.2.3. By
Disease
7.2.4. By
Technology
7.2.5. By Type
7.2.6.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Human Microbiome Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product
7.3.1.2.2.
By Application
7.3.1.2.3.
By Disease
7.3.1.2.4.
By Technology
7.3.1.2.5.
By Type
7.3.2.
India Human Microbiome Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product
7.3.2.2.2.
By Application
7.3.2.2.3.
By Disease
7.3.2.2.4.
By Technology
7.3.2.2.5.
By Type
7.3.3.
Japan Human Microbiome Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product
7.3.3.2.2.
By Application
7.3.3.2.3.
By Disease
7.3.3.2.4.
By Technology
7.3.3.2.5.
By Type
7.3.4.
South Korea Human Microbiome Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Product
7.3.4.2.2.
By Application
7.3.4.2.3.
By Disease
7.3.4.2.4.
By Technology
7.3.4.2.5.
By Type
7.3.5.
Australia Human Microbiome Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Product
7.3.5.2.2.
By Application
7.3.5.2.3.
By Disease
7.3.5.2.4.
By Technology
7.3.5.2.5.
By Type
8.
Europe Human Microbiome Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Product
8.2.2.
By Application
8.2.3.
By Disease
8.2.4.
By Technology
8.2.5.
By Type
8.2.6.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Human Microbiome Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product
8.3.1.2.2.
By Application
8.3.1.2.3.
By Disease
8.3.1.2.4.
By Technology
8.3.1.2.5.
By Type
8.3.2.
Germany Human Microbiome Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product
8.3.2.2.2.
By Application
8.3.2.2.3.
By Disease
8.3.2.2.4.
By Technology
8.3.2.2.5.
By Type
8.3.3.
United Kingdom Human Microbiome Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product
8.3.3.2.2.
By Application
8.3.3.2.3.
By Disease
8.3.3.2.4.
By Technology
8.3.3.2.5.
By Type
8.3.4.
Italy Human Microbiome Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product
8.3.4.2.2.
By Application
8.3.4.2.3.
By Disease
8.3.4.2.4.
By Technology
8.3.4.2.5.
By Type
8.3.5.
Spain Human Microbiome Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product
8.3.5.2.2.
By Application
8.3.5.2.3.
By Disease
8.3.5.2.4.
By Technology
8.3.5.2.5.
By Type
9.
North America Human Microbiome Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Product
9.2.2.
By Application
9.2.3.
By Disease
9.2.4.
By Technology
9.2.5.
By Type
9.2.6.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Human Microbiome Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product
9.3.1.2.2.
By Application
9.3.1.2.3.
By Disease
9.3.1.2.4.
By Technology
9.3.1.2.5.
By Type
9.3.2.
Mexico Human Microbiome Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product
9.3.2.2.2.
By Application
9.3.2.2.3.
By Disease
9.3.2.2.4.
By Technology
9.3.2.2.5.
By Type
9.3.3.
Canada Human Microbiome Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product
9.3.3.2.2.
By Application
9.3.3.2.3.
By Disease
9.3.3.2.4.
By Technology
9.3.3.2.5.
By Type
10.
South America Human Microbiome Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Product
10.2.2.
By Application
10.2.3.
By Disease
10.2.4.
By Technology
10.2.5.
By Type
10.2.6.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Human Microbiome Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Product
10.3.1.2.2.
By Application
10.3.1.2.3.
By Disease
10.3.1.2.4.
By Technology
10.3.1.2.5.
By Type
10.3.2.
Argentina Human Microbiome Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Product
10.3.2.2.2.
By Application
10.3.2.2.3.
By Disease
10.3.2.2.4.
By Technology
10.3.2.2.5.
By Type
10.3.3.
Colombia Human Microbiome Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Product
10.3.3.2.2.
By Application
10.3.3.2.3.
By Disease
10.3.3.2.4.
By Technology
10.3.3.2.5.
By Type
11.
Middle East and Africa Human Microbiome Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Product
11.2.2.
By Application
11.2.3.
By Disease
11.2.4.
By Technology
11.2.5.
By Type
11.2.6.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Human Microbiome Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Product
11.3.1.2.2.
By Application
11.3.1.2.3.
By Disease
11.3.1.2.4.
By Technology
11.3.1.2.5.
By Type
11.3.2.
Saudi Arabia Human Microbiome Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Product
11.3.2.2.2.
By Application
11.3.2.2.3.
By Disease
11.3.2.2.4.
By Technology
11.3.2.2.5.
By Type
11.3.3.
UAE Human Microbiome Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Product
11.3.3.2.2.
By Application
11.3.3.2.3.
By Disease
11.3.3.2.4.
By Technology
11.3.3.2.5.
By Type
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends & Developments
13.1.
Recent Developments
13.2.
Mergers & Acquisitions
13.3.
Product Developments
14.
Competitive Landscape
14.1.
Business Overview
14.2.
Company Snapshot
14.3.
Products & Services
14.4.
Financials (In case of listed companies)
14.5.
Recent Developments
14.6.
SWOT Analysis
14.6.1.
Enterome Bioscience SA
14.6.2.
Yakult Honsha Co. Ltd.
14.6.3.
4 D Pharma
14.6.4.
Evelo Biosciences
14.6.5.
Seres Therapeutics Inc.
14.6.6.
Vedanta Biosciences
14.6.7.
Second Genome Inc.
14.6.8.
Quantibiome
14.6.9.
Rebiotix Inc.
14.6.10.
Microbiome Therapeutics LLC
15. Strategic
Recommendations